Actively managed mid-cap growth strategy that relies on fundamental research and analysis to identify companies with strong and accelerating business momentum, increasing market acceptance and attractive valuations.
Key Takeaways
- After much speculation over when the seemingly inevitable recession would hit, markets have continued to defy the narrative with yet another strong quarter. Unemployment remains at historic lows and the economy has thus far shown itself to be much more resilient than expected.
- For the quarter, the Strategy outperformed its benchmark, the Russell Midcap Growth Index (the Index), on a net asset value (NAV) basis, due to favorable stock selection, particularly within the health care, information technology and consumer staples sectors.
- With inflation easing, it appears that the U.S. Federal Reserve is nearing the end of the rate hike cycle. We are cautiously optimistic that we can achieve the soft landing scenario.
Portfolio Review
U.S. equity markets performed well during the second quarter, with most of the gains made in June. Stocks were buoyed by relief over Congress’s passage of the bill to raise the debt ceiling. The S&P 500 Index notched its best monthly performance of 2023 during the final month of the period, gaining 6.61% in June and 8.74% for the quarter. Information technology stocks delivered strong performance during the quarter, driven by artificial intelligence and chip manufacturers. Growth stocks outperformed value stocks during the period. After poor performance in April and May, small caps rebounded in June and outperformed larger stocks.
Volatility in the U.S. bond market continued during the quarter. The Bloomberg U.S. Aggregate Bond Index lost –0.84%, while the 10-year U.S. Treasury yield rose from 3.43% at the beginning of the quarter to 3.81% by quarter-end. The Fed raised rates by 25 basis points twice during the period, bringing the Fed funds rate to a range of 5.00–5.25%, but did not implement a hike at its June meeting. Still, Fed officials maintained a hawkish stance through the end of the quarter; although core inflation has decreased significantly from 2022, it has persisted well above the 2% target. The Fed’s “dot plot,” which serves as a predictor of rate movements, indicates two additional hikes this year.
For the quarter, the Strategy outperformed the Index due to stock selection. Stock selection within the health care, information technology and consumer staples sectors contributed the most to performance. The materials and consumer discretionary sectors were the greatest detractors.
Key contributors to the quarter’s performance were Palo Alto Networks, Inc., Celsius Holdings, Inc. and MongoDB, Inc.
Owning a non-benchmark position in Palo Alto Networks, Inc. (PANW) contributed to performance. The company reported a strong quarter during the period. Demand appears to be tracking to the high end of guidance and demand increase for newer services suggests strong revenue growth going forward.
An overweight position in Celsius Holdings, Inc. (CELH) contributed to performance. The company reported a strong quarter with accelerating sales growth. CELH is also in discussions with Pepsico regarding entry into select international markets, likely beginning in 2024.
An overweight position in MongoDB, Inc. (MDB) contributed to performance. The company reported a strong quarter, with both revenue and margins coming in higher than anticipated. They also provided better-than-expected guidance.
Key detractors for the quarter were Amylyx Pharmaceuticals, Inc., Palantir Technologies Inc. and Tradeweb Markets, Inc.
Owning a non-benchmark position in Amylyx Pharmaceuticals, Inc. (AMLX) detracted from performance. The company received a negative opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on their application for conditional marketing authorization for AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS) in Europe.
Not owning a position in Palantir Technologies Inc. (PLTR) detracted from performance. The company reported mixed results during the period but management indicated that they plan to aggressively pursue the growing demands for AI.
An overweight position in Tradeweb Markets, Inc. (TW) detracted from performance. The company reported an in-line quarter, but lowered estimates on volume weakness.
Current strategy and outlook
The U.S. economy has remained resilient as have corporate earnings, fueling the debate of a hard versus soft landing. We still believe there may be greater volatility to come given uncertainty over Fed rate policy in the second half of the year; mixed business sentiment and slowing economic growth; and whether a recession will actually happen, and if so, the duration and depth. The real story has been the resilience of corporate earnings and rise in equity valuations as interest rates begin to normalize. Using price-to-earnings (P/E) ratio as a proxy, valuations for the S&P 500 Index ended 2022 well below 2019 levels. However, despite elevated rates and tightening financial conditions in the first half of the year, valuations have expanded modestly. P/E ratios are still below 2019 levels, and we believe earnings expectations are reasonable, but this could change as we enter 2024 depending on the state of the U.S. economy.
Holdings Detail
Companies mentioned in this report – percentage of portfolio investments, as of 06/30/23: Palo Alto Networks, Inc. 1.74%, Celsius Holdings, Inc. 0.80%, MongoDB, Inc. 1.82%, Amylyx Pharmaceuticals, Inc. 0.86%, Palantir Technologies Inc. 0% and Tradeweb Markets, Inc. 1.86%; 0% indicates that the security is no longer in the portfolio. Portfolio holdings are subject to daily change.